U.S. Markets close in 24 mins.

Array BioPharma Inc. (ARRY)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.205-0.175 (-2.088%)
As of 3:36PM EDT. Market open.
People also watch
EXELARQLCLDXRIGLFOLD
Full screen
Previous Close8.380
Open8.480
Bid8.260 x 2200
Ask8.270 x 1200
Day's Range8.150 - 8.490
52 Week Range3.100 - 13.400
Volume1,741,330
Avg. Volume3,441,723
Market Cap1.4B
Beta1.74
PE Ratio (TTM)-11.40
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacksyesterday

    New Strong Sell Stocks for July 20th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • American City Business Journals3 days ago

    Colorado biotech makes deal with industry giant

    A Boulder biotech said it's made a deal with an industry giant to develop drugs for autoimmune disorders. Array BioPharma Inc. (ARRY) said it's made a deal with giant Amgen Inc. (AMGN) of Thousand Oaks, California to take advantage of Array's inflammatory disease discoveries. "The identification of this novel target, along with our team's deep experience in kinase inhibitor chemistry, gives us confidence that our efforts will result in a drug which will address a significant unmet medical need for patients with inflammatory disease," said Nicholas Saccomano, chief scientific officer at Array, in a statement.

  • Capital Cube9 days ago

    ETFs with exposure to Array BioPharma, Inc. : July 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)